The Food & Drug Administration gives priority review to a Defense Advanced Research Projects Agency project aiming to create a robotic arm as the watchdog agency's first step on its "Innovation Pathway" proposal.

The Food & Drug Administration, aiming to blaze trail on a so-called "Innovation Pathway" designed to speed innovative medical technology to market, tapped a military project to create a prosthetic arm controlled by a brain-implanted microchip as its first speedy review candidate.
Pluristem is seeking clinical proof that stem cell therapy can benefit patients with chronic...
GE Healthcare introduces Mavric SL, a novel magnetic resonance imaging technique for joint...
Johnson & Johnson subsidiary DePuy Orthopaedics plans to phase out sales of all of its metal-on-...
The FDA approves a novel combat-ready clamp to treat wounds most commonly associated with roadside or...
Vascular Solutions CEO Howard Root says alleged infringement by Boston Scientific's Guidezilla "is...
Comments